Eurofins Ingenasa is taking part in SaPher project

by Ingenasa

Eurofins Ingenasa is taking part in SaPher project, aiming to develop the antibodies of interest not commercially available in the market for the target allergen industries.

Read more

Eurofins Ingenasa participates in the VACDIVA Project, which aims to develop an effective vaccine against African Swine Fever (ASFV)

by Ingenasa

The VACDIVA project has been financed with 10 million euros by the European Union (EU) in the call “H2020-SFS-2019-1, topic: A vaccine against African Swine Fever”. The research works involve two ...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio liderado por el Hospital Vir...

by Hospital Universitario Virgen de la Macarena

El estudio PROBAC-EC demuestra que la estructura poblacional de la bac...

Photos Stream